THE NEORAL FORMULATION - IMPROVED CORRELATION BETWEEN CYCLOSPORINE TROUGH LEVELS AND EXPOSURE IN STABLE RENAL-TRANSPLANT RECIPIENTS

被引：0
|
作者：
KAHAN, BD
DUNN, J
FITTS, C
VANBUREN, D
WOMBOLT, D
POLLAK, R
CARSON, R
ALEXANDER, JW
CHANG, C
CHOC, M
WONG, R
机构：
[1] UNIV CALIF SAN DIEGO,SAN DIEGO,CA
[2] MED UNIV S CAROLINA,CHARLESTON,SC
[3] VANDERBILT UNIV,NASHVILLE,TN
[4] EASTERN VIRGINIA MED SCH,NORFOLK,VA
[5] UNIV ILLINOIS,CHICAGO,IL
[6] UNIV TEXAS,GALVESTON,TX
[7] UNIV CINCINNATI,CINCINNATI,OH
[8] SANDOZ INC,RES INST,E HANOVER,NJ 07936
来源：
TRANSPLANTATION PROCEEDINGS | 1994年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2940 / 2943
页数：4
相关论文
共 50 条
  • [31] Conversion of cyclosporine (neoral;: CsA) to mycophenolate mofetil (MMF) in stable renal transplant recipients.
    Schrama, YC
    Hené, RJ
    Boer, P
    Koomans, HA
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1625 - 1626
  • [32] HYPERLIPIDEMIA IN STABLE RENAL-TRANSPLANT RECIPIENTS
    DIVAKAR, D
    BAILEY, RR
    FRAMPTON, CM
    GEORGE, PM
    WALMSLEY, TA
    MURPHY, J
    NEPHRON, 1991, 59 (03): : 423 - 428
  • [33] HEMODYNAMICS OF STABLE RENAL-TRANSPLANT RECIPIENTS
    KIM, KE
    BATES, O
    LYONS, P
    PITONE, J
    MARTINEZ, EW
    VALVO, E
    SABANAYAGAM, P
    BOWER, R
    SWARTZ, C
    ONESTI, G
    CLINICAL SCIENCE, 1980, 59 : S377 - S379
  • [34] COMPLICATIONS IN STABLE RENAL-TRANSPLANT RECIPIENTS
    DIVAKAR, D
    THIAGARAJAN, CM
    SHUNMUGASUNDARAM, D
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (05) : 1760 - 1760
  • [35] HYPERLIPEMIA IN STABLE RENAL-TRANSPLANT RECIPIENTS
    DIVAKAR, D
    BAILEY, RR
    GEORGE, P
    FRAMPTON, CM
    NEW ZEALAND MEDICAL JOURNAL, 1989, 102 (879) : 591 - 591
  • [36] Conversion to Neoral in stable renal transplant recipients.
    Pescovitz, MD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3360 - A3360
  • [37] RELATIONSHIP BETWEEN CYCLOSPORINE BIOAVAILABILITY AND CLINICAL OUTCOME IN RENAL-TRANSPLANT RECIPIENTS
    SCHROEDER, TJ
    HARIHARAN, S
    FIRST, MR
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2787 - 2790
  • [38] Pharmacokinetic, blood pressure, and renal effects of cyclosporine Sandimmune vs Neoral formulation in heart transplant recipients
    White, M
    Pelletier, GB
    Jesina, C
    Carrier, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 86178 - 86178
  • [39] Conversion from cyclosporine sandimmune to cyclosporine neoral in the stable renal transplant population
    Griffin, PJA
    Moore, RH
    Jurewicz, WA
    Lord, RHH
    Webley, Y
    Jenkins, J
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 303 - 303
  • [40] Cyclosporine trough levels comparison with AUC during conversion to microemulsion formulation (''Neoral'').
    Heifets, M
    Sellers, P
    Sallas, W
    Browne, B
    Samuels, LA
    Cooney, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3322 - A3322
12345